Skip to main content
Premium Trial:

Request an Annual Quote

Not Enough Training

"Today's trainees are sold promises that their hard work in the lab will pay off with tenure-track positions in academia," writes the American Society for Biochemistry and Molecular Biology's Benjamin Corb in a post at the organization's News From the Hill blog. "Nearly one in three biomedical PhDs will end up with a career in the private sector, and yet our community rarely if ever provides training to PhDs that will both prepare them for alternative careers and educate them on realistic employment options that will be available."

And so, Corb says, while groups like the US National Institutes of Health Advisory Committee to the Director's Biomedical Workforce Working Group have advocated for broad training options for biomedical PhDs, it is simply not enough. "If we are using NIH dollars to train PhDs for the research and academic careers we want for them but only 23 percent of them are reaching that goal, it is time to find answers to critical questions," he says.

Corb and the rest of ASBMB's public affairs team are soliciting suggestions for how to fix the PhD training problem, which they intend to submit to the NIH.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.